Rockland Immunochemicals, Inc.
Rockland Immunochemicals, Inc., a leading provider in the biotechnology sector, is headquartered in the United States. Founded in 1965, the company has established itself as a key player in the development and production of high-quality antibodies, proteins, and immunoassay reagents. With a focus on research and diagnostic applications, Rockland serves a diverse clientele, including academic institutions, pharmaceutical companies, and clinical laboratories. Renowned for its extensive catalogue of custom and off-the-shelf products, Rockland Immunochemicals stands out due to its commitment to quality and innovation. The company has achieved significant milestones, including the introduction of unique antibody validation techniques that enhance research reliability. With a strong market position, Rockland continues to contribute to advancements in immunology and related fields, solidifying its reputation as a trusted partner in scientific discovery.
DitchCarbon Score
How does Rockland Immunochemicals, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Rockland Immunochemicals, Inc.'s score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Rockland Immunochemicals, Inc.'s reported carbon emissions
Rockland Immunochemicals, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Rockland Immunochemicals may not have established formal climate commitments or initiatives aimed at reducing their carbon footprint. In the context of the industry, many organisations are increasingly adopting science-based targets and sustainability initiatives to mitigate climate change impacts. However, without specific emissions data or commitments, it is unclear how Rockland Immunochemicals aligns with these industry standards. As the company continues to operate, it may consider developing a strategy to address carbon emissions and enhance its environmental responsibility.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Rockland Immunochemicals, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
